NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-326-2002-1-US-01 Triplex Hairpin Ribozyme Directed Against Human Papillomavirus Type 16 (HPV-16) E6 And E7 MRNA US 60/480,815 Abandoned
NINDS E-084-2003-1-US-01 Identification, Quantification, and Characterization of T Cells and T Cell Antigens US 60/480,083 Abandoned
NIDDK E-143-2003-0-US-01 Tightly Binding Antibodies Directed Against The Internal Trimeric Coiled-coil Of GP41 Inhibit HIV-Envelope Mediated Cell Fusion US 60/480,070 Abandoned
NIDCD E-222-2003-0-US-01 Functional Variants of Human Taste Receptor Genes US 60/480,035 Abandoned
NCI E-056-2002-0-AU-06 SPECIFICITY GRAFTING OF A MURINE ANTIBODY ONTO A HUMAN FRAMEWORK AU National Stage 2003243651 Abandoned
NCI E-056-2002-0-PCT-02 SPECIFICITY GRAFTING OF A MURINE ANTIBODY ONTO A HUMAN FRAME WORK PCT PCT PCT/US03/19333 Expired
NCI E-056-2002-0-EP-05 SPECIFICITY GRAFTING OF A MURINE ANTIBODY ONTO A HUMAN FRAMEWORK EP National Stage 03760462.6 Abandoned
NCI E-056-2002-0-CA-04 SPECIFICITY GRAFTING OF A MURINE ANTIBODY ONTO A HUMAN FRAMEWORK CA National Stage 2487321 Abandoned
NCI E-175-2002-0-US-02 METHOD OF TREATING ISCHEMIA/REPERFUSION INJURY WITH NITROXYL DONORS US ORD 10/463,084 Abandoned
NINDS E-292-1999-0-US-05 LOW OXYGEN CULTURING OF CENTRAL NERVOUS SYSTEM PROGENITOR CELLS US DIV 10/462,896 Abandoned
NIAID E-093-2003-1-US-01 Recovery of Recombinant Human Metapneumovirus (HMPV) from cDNA and Use of Recombinant HMPV in Immunogenic Compositions and as Vectors to Elicit Immune Responses Against HMPV and Other Human Pathogens US 60/478,667 Abandoned
NIAID E-083-2005-0-US-01 Negative Strand RNA Virus Replicon US 60/478,521 Abandoned
NCI E-124-1996-0-US-05 FIBROBLAST GROWTH FACTOR RECEPTOR ACTIVATING GENE 1 AND RELATED COMPOSTITIONS AND METHODS US DIV 10/461,180 6831170 Expired PDF
NCI E-279-1999-0-US-03 AMINOFLAVONE COMPOUNDS, COMPOSITIONS, AND METHODS OF USE US National Stage 10/240,883 6812246 Abandoned PDF
NCI E-063-2003-0-US-01 Rapamycin Resistant T Cells and Therapeutic Uses Thereof US 60/478,736 Abandoned
NCI E-210-1998-0-US-05 Aspartic Protease Inhibitors US DIV 10/458,873 7132420 Abandoned PDF
NHGRI E-273-1999-2-US-03 Method And System For Processing Regions Of Interest For Objects Comprising Biological Material US National Stage 10/450,372 Abandoned
NCI E-306-2000-0-EP-03 CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHODS OF MAKING SAME. EP National Stage 03741911.6 Abandoned
NCI E-306-2000-0-PCT-02 CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHODS OF MAKING SAME. PCT PCT PCT/US03/018270 Expired
NCI E-046-1991-1-JP-25 METHOD OF PREVENTING TUMOR METASTASIS JP DIV 2003-165273 Abandoned
NCI E-135-2002-1-PCT-01 ANTI-CD30 STALK AND ANTI-CD-3 ANTIBODIES SUITABLE FOR USE IN IMMUNOTOXINS PCT PCT COMB PCT/US03/18373 Expired
NCI E-055-2002-0-PCT-02 Novel Stable Antie-CD22 Antibodies PCT PCT PCT/US03/18201 Expired
NIAID E-087-1997-0-US-05 STRL33, A Human Accessory Factor Associated with HIV Infection US CON 10/458,110 Abandoned
NCI E-237-2000-0-CA-05 Compositions And Methods related to The Minn 1 Tumor Suppressor Gene And Protein CA National Stage 2431585 Abandoned
ORS E-179-2002-0-US-01 Deliberately Enhanced Bio-indicater and Method of Use US 60/479,512 Abandoned
NCI E-008-2001-0-US-01 Compositions and Methods for Enhancing Differential Gene Expression US ORD 10/456,830 7598077 Abandoned PDF
NCI E-151-1998-0-US-08 Water-Insoluble Drug Delivery System US DIV 10/455,295 6838090 Abandoned PDF
NIMH E-257-2003-0-US-01 Two Enterocin-Producing Strains Of Bacteria And Their Enterocins,Both Of Which Are Lethal To Vancomycin-Resistant Enterococcus Faecium (VREF) And Are Useful For Therapy Of VREF Infections And For Eradication Of VREF Carriage US 60/475,782 Abandoned
NCI E-116-2003-0-US-01 Immunogenic Peptides And Peptide Derivatives For The Treatment of Prostate And Breast Cancer Treatment US 60/476,467 Abandoned
NICHD E-343-2002-0-US-01 Gamma PGA Conjugates For Eliciting Immune Responses Directed Against Bacillus Anthracis and Other Bacilli US 60/476,598 Abandoned
NCI E-063-2002-0-CA-06 SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME CA National Stage 2487908 Abandoned
NCI E-063-2002-0-AU-05 SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME AU National Stage 2003239952 Abandoned
NCI E-063-2002-0-PCT-03 SCORPIONATE-LIKE PENDANT MACROCYCLIC LIGANDS, COMPLEXES AND COMPOSITIONS THEREOF, AND METHODS OF USING SAME PCT PCT PCT/US03/17460 Expired
NIEHS E-026-2003-0-US-01 Method and System for Developing and Querying A Sequence Driven Contextual Knowledge Base US ORD 10/452,384 Abandoned
NIAAA E-007-2003-0-US-01 Nutritional Supplements and Therapeutic Compositions Comprising (R)-3-Hydroxybutayrate Derivatives US 60/475,848 Abandoned
NCI E-190-2002-2-US-03 Folliculin-Specific Antibodies And Methods of Detection US DIV 12/334,361 8003764 Abandoned PDF
NCI E-190-2002-2-PCT-01 Identification Of A Novel BHD Gene PCT PCT COMB PCT/US2003/17227 Expired
NHLBI E-306-2002-0-US-01 Identification of Proteins Using A Physical Parameter and Accurate Amino Acid Content US ORD 10/446,865 Abandoned
NCI E-021-2001-0-US-07 Chromosome 3p21.3 Genes Are Tumor Suppressors US DIV 10/445,718 7902441 Expired PDF
NIDCR E-171-1996-0-US-08 TARGETING ANTIGENTS TO THE MHC CLASS I PROCESSING PATHWAY WITH AN ANTHRAX TOXIN FUSION PROTEIN US DIV 10/446,890 7097965 Abandoned PDF
NCI E-014-1991-0-US-08 Pharmaceutical Compositions and Methods for Preventing Skin Tumor Formation and Causing Regression of Existing Tumors US CON 10/445,251 7056908 Expired PDF
NCI E-050-2000-0-NZ-07 Geldanamycin Derivative and Method of Treating Cancer Using Same NZ National Stage 526133 Expired
NCI E-022-1998-0-US-07 ALKENYLDIARYLMETHANE NON-NUCLEOSIDE HIV-1 REVERSE TRANSCRIPTASE INHBIBITORS (NNRTIS) US CON 10/445,430 Abandoned
NCI E-032-1996-0-US-09 Infectious Paillomavirs Pseudoviral Particles US CON 10/446,060 Abandoned
NIAID E-229-2003-0-US-01 GITR Ligand and Antibodies and Uses Thereof US 60/472,844 Abandoned
NCI E-225-2003-0-US-01 Protection Against Vertical Transmission Of Pathogenic Infections US 60/472,983 Abandoned
NHGRI E-167-2001-1-US-07 Hematopoietic Stem Cells Regenerate Infarcted Myocardium US CON 10/444,553 Abandoned
NCI E-327-2002-0-US-01 HIV Therapies US 60/472,965 Abandoned
NCI E-283-2000-0-US-03 A Chimeric Protein Comprising Non-Toxic Pseudomonas Exotoxin A and Type IV Pilin Sequences US National Stage 10/432,412 7314625 Abandoned PDF
NCI E-134-2000-0-US-02 Utilization of Non-Viral Sequences for Minus-Strand DNA Transfer and Gene Reconstitution US National Stage 10/276,602 7101541 Expired PDF